- Home
- TOWN vs PTGX Comparison
TOWN vs PTGX Comparison
Compare TOWN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOWN
- PTGX
- Stock Information
- Founded
- TOWN 1998
- PTGX 2006
- Country
- TOWN United States
- PTGX United States
- Employees
- TOWN N/A
- PTGX N/A
- Industry
- TOWN Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- TOWN Finance
- PTGX Health Care
- Exchange
- TOWN Nasdaq
- PTGX Nasdaq
- Market Cap
- TOWN 2.5B
- PTGX 2.8B
- IPO Year
- TOWN 1999
- PTGX 2016
- Fundamental
- Price
- TOWN $33.42
- PTGX $47.91
- Analyst Decision
- TOWN Buy
- PTGX Strong Buy
- Analyst Count
- TOWN 2
- PTGX 7
- Target Price
- TOWN $36.00
- PTGX $52.83
- AVG Volume (30 Days)
- TOWN 189.7K
- PTGX 450.1K
- Earning Date
- TOWN 10-23-2024
- PTGX 11-08-2024
- Dividend Yield
- TOWN 3.06%
- PTGX N/A
- EPS Growth
- TOWN N/A
- PTGX N/A
- EPS
- TOWN 2.00
- PTGX 2.75
- Revenue
- TOWN $671,844,000.00
- PTGX $319,120,000.00
- Revenue This Year
- TOWN N/A
- PTGX $400.33
- Revenue Next Year
- TOWN $10.45
- PTGX N/A
- P/E Ratio
- TOWN $16.38
- PTGX $17.54
- Revenue Growth
- TOWN N/A
- PTGX 125.73
- 52 Week Low
- TOWN $23.58
- PTGX $13.76
- 52 Week High
- TOWN $35.74
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- TOWN 50.13
- PTGX 60.40
- Support Level
- TOWN $31.75
- PTGX $45.33
- Resistance Level
- TOWN $33.38
- PTGX $48.89
- Average True Range (ATR)
- TOWN 0.94
- PTGX 1.28
- MACD
- TOWN -0.15
- PTGX 0.11
- Stochastic Oscillator
- TOWN 44.74
- PTGX 77.11
About TOWN TowneBank
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and Insurance Segment provides provide a wide array of insurance products, including property, casualty, life, and health insurance.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.